Product Information
Name:Tremelimumab
Synonyms:
- Ticilimumab
- CP-675206
Brand:Targetmol
Description:Tremelimumab, a CTLA-4 blocker, is used with Durvalumab to treat solid tumors like liver and lung cancer.
Notice:Our products are intended for lab use only. For any other use, please contact us.
Chemical properties
Molecular weight:146.3 kDa
Purity:SDS-PAGE:95.4%;SEC-HPLC:98.7%
Color/Form:Liquid
Technical inquiry about: Tremelimumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.